| Pharmaceutical active ingredients: |
| Abacavir SulfateLamivudineZidovudine |
| Available forms, composition and doses of Lamivudine; Zidovudine; Abacavir: |
| Tablets; Oral; Abacavir Sulfate 150 mg; Lamivudine 300 mg; Zidovudine 300 mg |
| Lamivudine; Zidovudine; Abacavir medical category: |
| Human:Nucleoside and nucleotide reverse transcriptase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AR04 - Zidovudine, Lamivudine and Abacavir |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Aurobindo |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Abacavir; Lamivudine | Abacavir Sulfate; Lamivudine | Matrix Laboratories |
| Abacavir; Lamivudine | Abacavir Sulfate; Lamivudine | Teva |
| Epzicom | Abacavir Sulfate; Lamivudine | GlaxoSmithKline; Shire; ViiV Healthcare |
| Kivexa | Abacavir Sulfate; Lamivudine | GlaxoSmithKline; ViiV Healthcare; Zuellig Pharma |
| Abacavir; Lamivudine; Zidovudine | Abacavir Sulfate; Lamivudine; Zidovudine | Mylan |
| Tricivir | Abacavir Sulfate; Lamivudine; Zidovudine | GlaxoSmithKline |
| Tricivir GDS12 | Abacavir Sulfate; Lamivudine; Zidovudine | GlaxoSmithKline |
| Triviro-ALZ | Abacavir Sulfate; Lamivudine; Zidovudine | Ranbaxy |
| Trizivir | Abacavir Sulfate; Lamivudine; Zidovudine | GlaxoSmithKline; Shire; ViiV Healthcare; Zuellig Pharma |
| Viro-ALZ | Abacavir Sulfate; Lamivudine; Zidovudine | Ranbaxy |